Reply to Pomara et al: A potential role for sTREM2 in PTSD?

This publication has 10 references indexed in Scilit:

• Microglia-mediated neuroimmune suppression in posttraumatic stress disorder
  Proceedings of the National Academy of Sciences, 2024
• Microglia-mediated neuroimmune suppression in PTSD is associated with anhedonia
  Proceedings of the National Academy of Sciences, 2024
• Microglia states and nomenclature: A field at its crossroads
  Neuron, 2022
• sTREM-1 promotes the phagocytic function of microglia to induce hippocampus damage via the PI3K–AKT signaling pathway
  Scientific Reports, 2022
• Soluble TREM2: Innocent bystander or active player in neurological diseases?
  Neurobiology of Disease, 2022
• From psychiatry to neurology: Psychedelics as prospective therapeutics for neurodegenerative disorders
  Journal of Neurochemistry, 2021
• Longitudinal biomarkers in amyotrophic lateral sclerosis
  Annals of Clinical and Translational Neurology, 2020
• Recent Developments in TSPO PET Imaging as A Biomarker of Neuroinflammation in Neurodegenerative Disorders
  International Journal of Molecular Sciences, 2019
• Early increase of CSF sTREM2 in Alzheimer’s disease is associated with tau related-neurodegeneration but not with amyloid-β pathology
  Molecular Neurodegeneration, 2019
• The Microglial Innate Immune Receptor TREM2 Is Required for Synapse Elimination and Normal Brain Connectivity
  Immunity, 2018